39 research outputs found

    Banisteriopsis Species: A Source of Bioactive of Potential Medical Application

    Get PDF
    In recent years, interest in further development of herbal or botanical drug products derived from traditional preparations has been increasing steadily. Plants have been used for thousands of years to treat health disorders and to prevent diseases including epidemics. Several research works have been developed to search for new natural products to be used in pharmaceutical products. Active compounds produced during secondary metabolism are responsible for the biological properties of the plant species and may be used to most diverse purposes, including treatment of several diseases. Banisteriopsis species has been described showing interesting activities by its use in popular medicine. The mainly use was described to production of the Ayahuasca, an Amazonian psychotropic plant tea obtained from Banisteriopsis caapi, which contains  betacarboline alkaloids, mainly harmine, harmaline and tetrahydroharmine. Other species of Banisteriopsis genus have been described with biological metabolites as antimicrobial, anticholinesterase, antianxiety and others. These biological activities were described chiefly by the presence of alkaloids, flavonoids, tannins. Thus, to stimulate the study into the Banisteriopsis genus, the purpose of the present review is to gather information on the use of the extracts and metabolites of Banisteriopsis species (Malpighiaceae) as a resource to diseases treatment or to pharmaceutical purposes

    Biotransformation of clovane derivatives. Whole cell fungi mediated domino synthesis of rumphellclovane A

    Get PDF
    Here we describe the biotransformation of clovane derivatives by filamentary fungi Pestalotiopsis palustris and Penicillium minioluteum, and the application of the latter to the synthesis and determination of the absolute configuration of rumphellclovane A (2). Methoxyclovanol (1), a growth inhibitor of the phytopathogen Botrytis cinerea, is metabolised by P. palustris to yield rumphellclovane A (2), a natural compound recently isolated from the gorgonian coral Rumphella antipathies, two new compounds, (1R,2S,5S,8R,9S,10R)-2-methoxyclovane-9,10-diol (5) and (1S,2S,5S,7R,8R,9R)-2-methoxyclovane-7,9- diol (6), hydroxylated in positions not easily accessed by classic synthetic chemistry, and clovanodiols 3 and 4. P. minioluteum is able to selectively transform methoxyclovanol (1) into clovanodiols 3 and 4 and, in turn, lactone 8, the putative intermediate in the above mentioned synthesis of rumphellclovane A (2), into compound 2 via a domino process. The ability of P. minioluteum to carry out the cleavage of ethers on clovane derivatives is also evaluated

    Phytotoxic Activity and Metabolism of Botrytis cinerea and Structure−Activity Relationships of Isocaryolane Derivatives

    Get PDF
    Research has been conducted on the biotransformation of (8S,9R)-isocaryolan- 9-ol (4a) and (1S,2S,5R,8S)-8 methylene-1,4,4-trimethyltricyclo[6.2.1.02,5]undecan-12-ol (5a) by the fungal phytopathogen Botrytis cinerea. The biotransformation of compound 4a yielded compounds 6−9, while the biotransformation of compound 5a yielded compounds 10−13. The activity of compounds 4a and 5a against B. cinerea has been evaluated. (8R,9R)- Isocaryolane-8,9-diol (6), a major metabolite of compound 4a, shows activity compared to its parent compound 4a, which is inactive. The effect of isocaryolanes 3, 4a, and 5a, together with their biotransformation products 6−8, 10, and 14−17, on the germination and radicle and shoot growth of Lactuca sativa (lettuce) has also been determined. Compounds 7−13 are described for the first time

    Análise da rotulagem de bebidas mistas de frutas e vegetais denominadas detox

    Get PDF
    Introduction:Labels provide information to guide consumers about the most appropriate food choices for their needs, being an important channel of communication between the consumer and the food producer. To fulfill this role, it is essential that these are correct and meet the established legal parameters. Objective:To evaluate the conformity of labels of industrialized mixed drinks based on fruits and vegetables that had the name “detox juice”, in products marketed in Belo Horizonte, Minas Gerais (MG), Brazil, between the years 2017 and 2019. Method:23 mixed drinks were initially selected and after evaluating the exclusion criteria, seven samples of different brands were included in this study. The analysis of the labeling was carried out according to the current regulation for food in Brazilian legislation, using a checklist with the following mandatory items: product name; list of ingredients; liquid content; origin identification; batch identification; expiration date; conservation care; use of phrases and images that may cause errors or mistakes to the consumer; nutritional labeling; warning about gluten and the registration number of beverages at the Ministry of Agriculture and Livestock and Supply (MAPA). Results:In 100% (n = 7) of the samples, irregularity in the use of the term “detox” on the labels and absence of registration with MAPA were observed. In 70% (n = 5) they had errors in the list of ingredients and nutritional information and in 57% (n = 4) the information on the liquid content was not correct. Conclusions: The results showed the presence of non-conformities in all the analyzed products. The irregularities in relation to the sales denomination and the absence of registration were highlighted. In view of this, it is emphasized the need for companies to adapt to the regulation of food labeling and the importance of promoting actions that allow consumers access to reliable information about these foods. Introdução:Os rótulos fornecem informações para a orientação do consumidor sobre as escolhas alimentares mais adequadas às suas necessidades, sendo um importante canal de comunicação entre o consumidor e o produtor de alimentos. Para cumprir esse papel, é fundamental que essas estejam corretas e atendam aos parâmetros legais estabelecidos. Objetivo:Avaliar a conformidade dos rótulos das bebidas mistas industrializadas à base de frutas e vegetais que apresentavam a denominação suco detox, comercializadas em Belo Horizonte (MG), Brasil, entre os anos de 2017 e 2019. Método:Foram selecionadas inicialmente 23 bebidas mistas e, após a avaliação dos critérios de exclusão, sete amostras de diferentes marcas foram selecionadas para o estudo. A análise da rotulagem foi realizada conforme a regulamentação vigente para alimentos na legislação brasileira, utilizando um checklist com os seguintes itens obrigatórios: denominação do produto; lista de ingredientes; conteúdo líquido; identificação de origem; identificação de lote; prazo de validade; cuidados de conservação; uso de frases e imagens que podem causar erro ou engano ao consumidor; rotulagem nutricional; advertência sobre o glúten e o número do registro das bebidas no Ministério da Agricultura e Pecuária e Abastecimento (MAPA). Resultados:Em 100% (n = 7) das amostras foi observada a irregularidade do uso do termo detoxnos rótulos e ausência do registro junto ao MAPA. Setenta por cento (n = 5) apresentavam erros na lista de ingredientes e informação nutricional e em 57% (n = 4) não estava correta a informação do conteúdo líquido. Conclusões:Os resultados evidenciaram a presença de não conformidades em todos os produtos analisados. Destacaram-se as irregularidades em relação à denominação de venda e a ausência de registro. Diante disso, enfatiza-se a necessidade de adequação das empresas frente à regulação da rotulagem dos alimentos e a importância de se promover ações que permitam aos consumidores acesso a informações confiáveis sobre esses alimentos

    Inhibition of Acetylcholinesterase and Fatty Acid Composition in Theobroma grandiflorum Seeds

    Get PDF
    Theobroma grandiflorum is an important fruit tree from Sterculiaceae family, native to the Brazilian Amazon, known in the region as cupuaçu. The seeds have a high fat content (24%) with characteristics that resemble those of cocoa (Theobroma cacao) butter with potential applications in the cosmetic, pharmaceutical and food industries. The main objective of this work was to explore the seed fats from T. grandiflorum that were analyzed for fatty acid composition by Gas Chromatography with Flame Ionization Detector (GC-FID) and to analyze their activity for acetylcholinesterase inhibition. Chromatographic analysis provided detection of nine fatty acids. The major fatty acids found in the species were oleic (40.0%), stearic (32.7%), arachidic (10.4%) and palmitic (8.0%). The acetylcholinesterase inhibition by fats from seeds was over 40.48%. DOI: http://dx.doi.org/10.17807/orbital.v0i0.89

    Synthesis, Fungitoxic Activity against Botrytis cinerea and Phytotoxicity of Alkoxyclovanols and Alkoxyisocaryolanols

    Get PDF
    Clovane and isocaryolane derivatives have been proven to show several levels of activity against the phytopathogenic fungus Botrytis cinerea. Both classes of sesquiterpenes are reminiscent of biosynthetic intermediates of botrydial, a virulence factor of B. cinerea. Further development of both classes of antifungal agent requires exploration of the structure-activity relationships for the antifungal effects on B. cinerea and phytotoxic effects on a model crop. In this paper, we report on the preparation of a series of alkoxy-clovane and -isocaryolane derivatives, some of them described here for the first time (2b, 2d, 2f-2h, and 4c-4e); the evaluation of their antifungal properties against B. cinerea, and their phytotoxic activites on the germination of seeds and the growth of radicles and shoots of Lactuca sativa (lettuce). Both classes of compound show a correlation of antifungal activity with the nature of side chains, with the best activity against B. cinerea for 2d, 2h, 4c and 4d. In general terms, while 2-alkoxyclovan-9-ols (2a-2e) exert a general phytotoxic effect, this is not the case for 2-arylalkoxyclovan-9-ols (2f-2i) and 8-alkoxyisocaryolan-9-ols (4a-4d), where stimulating effects would make them suitable candidates for application to plants.This research was supported by a grant from Ministerio de Ciencia, Innovacion y Universidades (RTI2018-097356-B-C21, MCIU/AEI/FEDER, EU). A.d.A.P.B., G.G.d.S. and J.A.T. thank Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES, Brazil) for research fellowships (CAPES-DGU 197/09)

    Oil in Inajá Pulp (Maximiliana maripa): Fatty Acid Profile and Anti-acetylcholinesterase Activity

    Get PDF
    The inajá (Maximiliana maripa) is a palm from Arecaceae family. The inajá distribution occurs from Amazon to the west-central of South America. The inajá has edible parts: the palm heart and oils obtained from pulp and seed. The aims of this study were to verify the fatty acid profile from pulp oil by GC-FID and analyzing acetylcholinesterase inhibition by inajá pulp oil. Chromatographic analysis provided eleven fatty acids. The major unsaturated fatty acids are oleic (22.32%), linoleic (4.72%) and linolenic acids (3.95%). The major saturated fatty acids are palmitic (20.76%), myristic (20.48%) and lauric acids (17.42%). The acetylcholinesterase inhibition by inajá oil pulp was over 63.76%. DOI: http://dx.doi.org/10.17807/orbital.v7i4.76

    Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    Get PDF
    Background: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 risk factors in 204 countries and territories and 811 subnational locations, from 1990 to 2021. Methods: The GBD 2021 risk factor analysis used data from 54 561 total distinct sources to produce epidemiological estimates for 88 risk factors and their associated health outcomes for a total of 631 risk–outcome pairs. Pairs were included on the basis of data-driven determination of a risk–outcome association. Age-sex-location-year-specific estimates were generated at global, regional, and national levels. Our approach followed the comparative risk assessment framework predicated on a causal web of hierarchically organised, potentially combinative, modifiable risks. Relative risks (RRs) of a given outcome occurring as a function of risk factor exposure were estimated separately for each risk–outcome pair, and summary exposure values (SEVs), representing risk-weighted exposure prevalence, and theoretical minimum risk exposure levels (TMRELs) were estimated for each risk factor. These estimates were used to calculate the population attributable fraction (PAF; ie, the proportional change in health risk that would occur if exposure to a risk factor were reduced to the TMREL). The product of PAFs and disease burden associated with a given outcome, measured in disability-adjusted life-years (DALYs), yielded measures of attributable burden (ie, the proportion of total disease burden attributable to a particular risk factor or combination of risk factors). Adjustments for mediation were applied to account for relationships involving risk factors that act indirectly on outcomes via intermediate risks. Attributable burden estimates were stratified by Socio-demographic Index (SDI) quintile and presented as counts, age-standardised rates, and rankings. To complement estimates of RR and attributable burden, newly developed burden of proof risk function (BPRF) methods were applied to yield supplementary, conservative interpretations of risk–outcome associations based on the consistency of underlying evidence, accounting for unexplained heterogeneity between input data from different studies. Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. Findings: Among the specific risk factors analysed for this study, particulate matter air pollution was the leading contributor to the global disease burden in 2021, contributing 8·0% (95% UI 6·7–9·4) of total DALYs, followed by high systolic blood pressure (SBP; 7·8% [6·4–9·2]), smoking (5·7% [4·7–6·8]), low birthweight and short gestation (5·6% [4·8–6·3]), and high fasting plasma glucose (FPG; 5·4% [4·8–6·0]). For younger demographics (ie, those aged 0–4 years and 5–14 years), risks such as low birthweight and short gestation and unsafe water, sanitation, and handwashing (WaSH) were among the leading risk factors, while for older age groups, metabolic risks such as high SBP, high body-mass index (BMI), high FPG, and high LDL cholesterol had a greater impact. From 2000 to 2021, there was an observable shift in global health challenges, marked by a decline in the number of all-age DALYs broadly attributable to behavioural risks (decrease of 20·7% [13·9–27·7]) and environmental and occupational risks (decrease of 22·0% [15·5–28·8]), coupled with a 49·4% (42·3–56·9) increase in DALYs attributable to metabolic risks, all reflecting ageing populations and changing lifestyles on a global scale. Age-standardised global DALY rates attributable to high BMI and high FPG rose considerably (15·7% [9·9–21·7] for high BMI and 7·9% [3·3–12·9] for high FPG) over this period, with exposure to these risks increasing annually at rates of 1·8% (1·6–1·9) for high BMI and 1·3% (1·1–1·5) for high FPG. By contrast, the global risk-attributable burden and exposure to many other risk factors declined, notably for risks such as child growth failure and unsafe water source, with age-standardised attributable DALYs decreasing by 71·5% (64·4–78·8) for child growth failure and 66·3% (60·2–72·0) for unsafe water source. We separated risk factors into three groups according to trajectory over time: those with a decreasing attributable burden, due largely to declining risk exposure (eg, diet high in trans-fat and household air pollution) but also to proportionally smaller child and youth populations (eg, child and maternal malnutrition); those for which the burden increased moderately in spite of declining risk exposure, due largely to population ageing (eg, smoking); and those for which the burden increased considerably due to both increasing risk exposure and population ageing (eg, ambient particulate matter air pollution, high BMI, high FPG, and high SBP). Interpretation: Substantial progress has been made in reducing the global disease burden attributable to a range of risk factors, particularly those related to maternal and child health, WaSH, and household air pollution. Maintaining efforts to minimise the impact of these risk factors, especially in low SDI locations, is necessary to sustain progress. Successes in moderating the smoking-related burden by reducing risk exposure highlight the need to advance policies that reduce exposure to other leading risk factors such as ambient particulate matter air pollution and high SBP. Troubling increases in high FPG, high BMI, and other risk factors related to obesity and metabolic syndrome indicate an urgent need to identify and implement interventions
    corecore